These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1892154)

  • 1. Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenge.
    Halvorsen SM; Dull WL
    Am J Med; 1991 Sep; 91(3):315-7. PubMed ID: 1892154
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenazopyridine-induced sulfhemoglobinemia.
    Gopalachar AS; Bowie VL; Bharadwaj P
    Ann Pharmacother; 2005 Jun; 39(6):1128-30. PubMed ID: 15886294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon.
    Kermani TA; Pislaru SV; Osborn TG
    J Clin Rheumatol; 2009 Apr; 15(3):127-9. PubMed ID: 19300288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Phenazopyridine-Induced Sulfhemoglobinemia in an 83-Year-Old Presenting with Dyspnea.
    Morales A; Walsh R; Brown W; Checinski P; Williams SR
    J Emerg Med; 2021 Aug; 61(2):147-150. PubMed ID: 34034895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Enterogenous" cyanosis.
    Lim TP; Lower D
    Am Rev Respir Dis; 1970 Mar; 101(3):419-22. PubMed ID: 5414061
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfhemoglobinemia after dermal application of DMSO.
    Burgess JL; Hamner AP; Robertson WO
    Vet Hum Toxicol; 1998 Apr; 40(2):87-9. PubMed ID: 9554060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of an antalgic-induced (Phenacetin + Acetanilid) sulf and methemoglobinemia in a woman receiving an antimetabolite (Methotrexate) (author's transl)].
    Muller A; Laugner B; Reiss F
    Anesth Analg (Paris); 1981; 38(9-10):551-3. PubMed ID: 7332102
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfhemoglobinemia in a 53-Year-Old With a History of Phenazopyridine Misuse.
    Soderstrom M; Foster DV; Hamidi ZS; Anderson JT
    Cureus; 2023 Jun; 15(6):e40944. PubMed ID: 37496545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired methaemoglobinaemia related to phenazopyridine ingestion.
    Shahani L; Sattovia S
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomethemoglobinemia: a case report and review of sulfhemoglobinemia.
    Lu HC; Shih RD; Marcus S; Ruck B; Jennis T
    Arch Pediatr Adolesc Med; 1998 Aug; 152(8):803-5. PubMed ID: 9701142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenacetin-induced sulfhemoglobinemia: report of a case and review of the literature.
    Kneezel LD; Kitchens CS
    Johns Hopkins Med J; 1976 Oct; 139(4):175-7. PubMed ID: 978859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired sulfhemoglobinemia. An underreported diagnosis?
    Noor M; Beutler E
    West J Med; 1998 Dec; 169(6):386-9. PubMed ID: 9866446
    [No Abstract]   [Full Text] [Related]  

  • 13. Metoclopramide-induced sulfhemoglobinemia.
    Van Veldhuizen PJ; Wyatt A
    Am J Gastroenterol; 1995 Jun; 90(6):1010-1. PubMed ID: 7771397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of sulfhemoglobin using various drugs].
    Nomura A
    Nihon Yakurigaku Zasshi; 1975 May; 71(4):351-65. PubMed ID: 1237450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic anemia and sulfhemoglobinemia due to phenacetin abuse: a case with multivisceral adverse effects.
    Basset P; Bergerat JP; Lang JM; Oberling F; Gillet B
    Clin Toxicol; 1981 Apr; 18(4):493-9. PubMed ID: 7237975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenazopyridine-induced hemolytic anemia in advanced kidney disease.
    Chang LC; Kuo CW; Chau T; Lin SH
    J Am Geriatr Soc; 2014 Dec; 62(12):2464-6. PubMed ID: 25516057
    [No Abstract]   [Full Text] [Related]  

  • 17. Lemon-yellow nails and long-term phenazopyridine use.
    Amit G; Halkin A
    Ann Intern Med; 1997 Dec; 127(12):1137. PubMed ID: 9412335
    [No Abstract]   [Full Text] [Related]  

  • 18. Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood.
    Van Leeuwen SR; Baranoski GVG; Kimmel BW
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():4570-4573. PubMed ID: 29060914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute drug-induced hemolytic anemia associated with met- and sulfhemoglobinemia (glucose-6-phosphate dehydrogenase deficiency in the erythrocytes)].
    Kushakovskiĭ MS
    Probl Gematol Pereliv Krovi; 1966 Jun; 11(6):59-63. PubMed ID: 5990681
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenazopyridine-induced methemoglobinemia.
    Terrell JR; Spruill WJ; Parish RC; Jenkins FH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):915. PubMed ID: 3234262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.